IBDEI0SV ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13279,0)
 ;;=E11.359^^80^758^20
 ;;^UTILITY(U,$J,358.3,13279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13279,1,3,0)
 ;;=3^DM Type 2 w/ Prolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,13279,1,4,0)
 ;;=4^E11.359
 ;;^UTILITY(U,$J,358.3,13279,2)
 ;;=^5002641
 ;;^UTILITY(U,$J,358.3,13280,0)
 ;;=E11.351^^80^758^21
 ;;^UTILITY(U,$J,358.3,13280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13280,1,3,0)
 ;;=3^DM Type 2 w/ Prolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,13280,1,4,0)
 ;;=4^E11.351
 ;;^UTILITY(U,$J,358.3,13280,2)
 ;;=^5002640
 ;;^UTILITY(U,$J,358.3,13281,0)
 ;;=E11.349^^80^758^22
 ;;^UTILITY(U,$J,358.3,13281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13281,1,3,0)
 ;;=3^DM Type 2 w/ Severe NonProlif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,13281,1,4,0)
 ;;=4^E11.349
 ;;^UTILITY(U,$J,358.3,13281,2)
 ;;=^5002639
 ;;^UTILITY(U,$J,358.3,13282,0)
 ;;=E11.341^^80^758^23
 ;;^UTILITY(U,$J,358.3,13282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13282,1,3,0)
 ;;=3^DM Type 2 w/ Severe NonProlif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,13282,1,4,0)
 ;;=4^E11.341
 ;;^UTILITY(U,$J,358.3,13282,2)
 ;;=^5002638
 ;;^UTILITY(U,$J,358.3,13283,0)
 ;;=E11.339^^80^758^18
 ;;^UTILITY(U,$J,358.3,13283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13283,1,3,0)
 ;;=3^DM Type 2 w/ Moderate NonProlif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,13283,1,4,0)
 ;;=4^E11.339
 ;;^UTILITY(U,$J,358.3,13283,2)
 ;;=^5002637
 ;;^UTILITY(U,$J,358.3,13284,0)
 ;;=E11.331^^80^758^19
 ;;^UTILITY(U,$J,358.3,13284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13284,1,3,0)
 ;;=3^DM Type 2 w/ Moderate NonProlif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,13284,1,4,0)
 ;;=4^E11.331
 ;;^UTILITY(U,$J,358.3,13284,2)
 ;;=^5002636
 ;;^UTILITY(U,$J,358.3,13285,0)
 ;;=E11.329^^80^758^16
 ;;^UTILITY(U,$J,358.3,13285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13285,1,3,0)
 ;;=3^DM Type 2 w/ Mild NonProlif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,13285,1,4,0)
 ;;=4^E11.329
 ;;^UTILITY(U,$J,358.3,13285,2)
 ;;=^5002635
 ;;^UTILITY(U,$J,358.3,13286,0)
 ;;=E11.321^^80^758^17
 ;;^UTILITY(U,$J,358.3,13286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13286,1,3,0)
 ;;=3^DM Type 2 w/ Mild NonProlif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,13286,1,4,0)
 ;;=4^E11.321
 ;;^UTILITY(U,$J,358.3,13286,2)
 ;;=^5002634
 ;;^UTILITY(U,$J,358.3,13287,0)
 ;;=E11.319^^80^758^24
 ;;^UTILITY(U,$J,358.3,13287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13287,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,13287,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,13287,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,13288,0)
 ;;=E11.311^^80^758^25
 ;;^UTILITY(U,$J,358.3,13288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13288,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,13288,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,13288,2)
 ;;=^5002632
 ;;^UTILITY(U,$J,358.3,13289,0)
 ;;=E10.9^^80^758^13
 ;;^UTILITY(U,$J,358.3,13289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13289,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,13289,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,13289,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,13290,0)
 ;;=E10.311^^80^758^11
 ;;^UTILITY(U,$J,358.3,13290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13290,1,3,0)
 ;;=3^DM Type 1 w/ Unspec Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,13290,1,4,0)
 ;;=4^E10.311
